Dong-A Socio Holdings Co., Ltd. (KRX:000640)
110,700
+300 (0.27%)
At close: Sep 8, 2025
Dong-A Socio Holdings Revenue
Dong-A Socio Holdings had revenue of 346.90B KRW in the quarter ending June 30, 2025, with 6.91% growth. This brings the company's revenue in the last twelve months to 1.38T, up 12.95% year-over-year. In the year 2024, Dong-A Socio Holdings had annual revenue of 1.33T with 17.78% growth.
Revenue (ttm)
1,379.12B
Revenue Growth
+12.95%
P/S Ratio
0.52
Revenue / Employee
16.62B
Employees
83
Market Cap
712.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,333.23B | 201.23B | 17.78% |
Dec 31, 2023 | 1,132.00B | 117.14B | 11.54% |
Dec 31, 2022 | 1,014.86B | 132.92B | 15.07% |
Dec 31, 2021 | 881.94B | 98.63B | 12.59% |
Dec 31, 2020 | 783.32B | 13.63B | 1.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |